SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-19-029440
Filing Date
2019-08-06
Accepted
2019-08-06 16:58:14
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 xene-s3.htm S-3 445257
2 EX-5.1 xene-ex51_8.htm EX-5.1 60338
3 EX-23.1 xene-ex231_6.htm EX-23.1 19808
4 GRAPHIC g1obnp2xh1kq000002.jpg GRAPHIC 14552
5 GRAPHIC g1q0nzjimogn000001.jpg GRAPHIC 3807
6 GRAPHIC g1q0nzjimogn000002.jpg GRAPHIC 37816
7 GRAPHIC g1q0nzjimogn000003.jpg GRAPHIC 3807
8 GRAPHIC g1obnp2xh1kq000001.jpg GRAPHIC 4652
9 GRAPHIC gxyxvmqeo5h4000001.jpg GRAPHIC 2469
  Complete submission text file 0001564590-19-029440.txt   619689
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-233056 | Film No.: 191002893
SIC: 2834 Pharmaceutical Preparations